To Lyse or Not: The Role of Half‐Dose Thrombolysis in Right Ventricular Clot Associated With Sub‐Massive Pulmonary Embolism
Nasreldin A. Hamza, Wasfy J. Hamad, Shamim K. Vakkulathil, Vimalraj Sundaram, Haidar M. Hadi, Abdulqadir J. Nashwan
TL;DR
A 43-year-old man with a rare heart clot and lung blockage successfully recovered using half the standard clot-dissolving treatment.
Contribution
Demonstrates successful use of half-dose thrombolysis for right ventricular clot in sub-massive pulmonary embolism.
Findings
Half-dose thrombolytic therapy resolved the right ventricular clot effectively.
The patient showed no complications after treatment.
The case suggests half-dose thrombolysis may be a viable treatment option.
Abstract
Right heart thrombi are rare but carry a high mortality risk. Appropriate therapy remains unclear; options include anticoagulation, thrombolysis, and surgical thrombectomy. In this case, a 43‐year‐old male with DVT, RV thrombus, and bilateral pulmonary embolism responded well to half‐dose thrombolytic therapy, with complete thrombus resolution and no complications.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsVenous Thromboembolism Diagnosis and Management · Cardiac tumors and thrombi · Atrial Fibrillation Management and Outcomes